Tanezumab in Osteoarthritis of the Knee

NCT00733902 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
697
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer